R. W. Stevenson

发表

Enhanced peripheral glucose utilization in transgenic mice expressing the human GLUT4 gene.

R. McPherson, J. Treadway, J. Pessin, 1994, The Journal of biological chemistry.

Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds.

J. Parsons, P. Meunier, J. Reeve, 1983, Endocrinology.

GLUT4 overexpression in db/db mice dose-dependently ameliorates diabetes but is not a lifelong cure.

T. Reynolds, S. Cushman, J. Brozinick, 2001, Diabetes.

In vitro and in vivo characterization of 3-[2-[6-(2-tert-butoxyethoxy)pyridin-3-yl]-1H-imidazol-4-yl]benzonitrile hydrochloride salt, a potent and selective NPY5 receptor antagonist.

T. Maurer, D. Hargrove, C. Mack, 2003, Journal of medicinal chemistry.

Role of Gluconeogenesis in Sustaining Glucose Production During Hypoglycemia Caused by Continuous Insulin Infusion in Conscious Dogs

A. Cherrington, G. Hendrick, R. K. Carr, 1988, Diabetes.

Stimulation of Glucose Production Through Hormone Secretion and Other Mechanisms During Insulin-Induced Hypoglycemia

E. Donahue, A. Cherrington, G. Hendrick, 1988, Diabetes.

Comparison of the metabolic responses to portal and peripheral infusions of insulin in diabetic dogs.

K. Alberti, J. Parsons, R. W. Stevenson, 1981, Metabolism: clinical and experimental.

INSULIN INFUSION INTO THE PORTAL AND PERIPHERAL CIRCULATIONS OF UNANAESTHETIZED DOGS

K. Alberti, J. Parsons, R. W. Stevenson, 1978, Clinical endocrinology.

The effects of lactate loading on alanine and glucose metabolism in the conscious dog.

D. Wasserman, A. Cherrington, D. Neal, 1993, Metabolism: clinical and experimental.

The Antihyperglycemic Agent Englitazone Prevents the Defect in Glucose Transport in Rats Fed a High-Fat Diet

R. McPherson, E. M. Gibbs, A. Swick, 1996, Diabetes.

Insulinlike Activity of New Antidiabetic Agent CP 68722 in 3T3-L1 Adipocytes

E. M. Gibbs, R. W. Stevenson, D. Kreutter, 1990, Diabetes.

Antidiabetic agent englitazone enhances insulin action in nondiabetic rats without producing hypoglycemia.

R. McPherson, B. H. Danbury, R. W. Stevenson, 1991, Metabolism: clinical and experimental.

Actions of Novel Antidiabetic Agent Englitazone in Hyperglycemic Hyperinsulinemic ob/ob Mice

R. McPherson, R. Volkmann, E. M. Gibbs, 1990, Diabetes.

Metabolic responses to intraduodenal glucose loading in insulin-infused diabetic dogs.

K. Alberti, H. Orskov, J. Parsons, 1983, The American journal of physiology.

The effects of epinephrine on ketogenesis in the dog after a prolonged fast.

A. Cherrington, R. W. Stevenson, B. Adkins-Marshall, 1991, Metabolism: clinical and experimental.

K. Alberti, A. Cherrington, P. Williams, 1991, The American journal of physiology.

Regulation of glucose metabolism by norepinephrine in conscious dogs.

K. Alberti, A. Cherrington, D. Neal, 1991, The American journal of physiology.

Regulation of lipolysis and ketogenesis by norepinephrine in conscious dogs.

K. Alberti, A. Cherrington, D. Neal, 1991, The American journal of physiology.

Effect of somatostatin on glucose homeostasis in conscious long-fasted dogs.

A. Cherrington, G. Hendrick, R. W. Stevenson, 1987, The American journal of physiology.

Lack of effect of somatostatin on epinephrine-stimulated glucose production in the dog.

A. Cherrington, P. Williams, R. W. Stevenson, 1987, Metabolism: clinical and experimental.

Regulation of Ketogenesis by Epinephrine and Norepinephrine in the Overnight-fasted, Conscious Dog

K. Alberti, A. Cherrington, P. Williams, 1985, Diabetes.

Effect of epinephrine on glycogenolysis and gluconeogenesis in conscious overnight-fasted dogs.

K. Alberti, A. Cherrington, P. Williams, 1984, The American journal of physiology.

Mechanism of epinephrine's glycogenolytic effect in isolated canine hepatocytes.

A. Cherrington, R. W. Stevenson, D. R. Green, 1985, Metabolism: clinical and experimental.

Role of glucagon suppression on gluconeogenesis during insulin treatment of the conscious diabetic dog

A. Cherrington, P. Williams, R. W. Stevenson, 1987, Diabetologia.

The Relationship between Plasma Concentration and Disappearance Rate of Immunoreactive Insulin in the Conscious Dog

A. Cherrington, R. W. Stevenson, K. Steiner, 1985, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Lack of effect of somatostatin on the stimulation of hepatic glycogenolysis by epinephrine in isolated canine hepatocytes.

A. Cherrington, R. W. Stevenson, D. R. Green, 1984, Biochimica et biophysica acta.

Matched glucose responses to insulin administered subcutaneously and intravenously

J. Parsons, R. W. Stevenson, T. I. Tsakok, 1980, Diabetologia.

An homologous and sensitive radioimmunoassay for the synthetic amino-terminal (1-34) fragment of human parathyroid hormone: application to the clearance of this peptide administered in vivo.

J. Parsons, B. Rafferty, R. W. Stevenson, 1980, Journal of immunoassay.

Glucose-dependent action of glucagon-like peptide-1 (7-37) in vivo during short- or long-term administration.

D. Hargrove, N. A. Nardone, R. W. Stevenson, 1995, Metabolism: clinical and experimental.

Effect of intraportal and peripheral insulin on glucose turnover and recycling in diabetic dogs.

K. Alberti, J. Parsons, R. W. Stevenson, 1983, The American journal of physiology.

P. Donahue, A. Cherrington, G. Hendrick, 1987, Diabetes.

Chapter 22. New Approaches to Diabetes

R. W. Stevenson, D. Clark, R. LarsonEric, 1990 .

Intracellular digestion of saturated and unsaturated phospholipid liposomes by mucosal cells. Possible mechanism of transport of liposomally entrapped macromolecules across the isolated vascularly perfused rabbit ileum.

H. Patel, R. W. Stevenson, N. S. Tuzel, 1985, Biochimica et biophysica acta.

Acute hormonal regulation of gluconeogenesis in the conscious dog.

A. Cherrington, M. Wada, R. Goldstein, 1993, Advances in experimental medicine and biology.

Actions of the novel antidiabetic agent englitazone in rat hepatocytes.

R. McPherson, P. Blackmore, R. W. Stevenson, 1993, Metabolism: clinical and experimental.

Amylin and CGRP induce insulin resistance via a receptor distinct from cAMP-coupled CGRP receptor.

S. Oreña, R. W. Stevenson, D. Kreutter, 1993, The American journal of physiology.

Structure-activity relationship studies on 2-heteroaryl-4-arylimidazoles NPY5 receptor antagonists.

T. Maurer, C. Mack, Robert M. Oliver, 2003, Bioorganic & medicinal chemistry letters.

INSULIN VIA CONTINUOUS SUBCUTANEOUS INFUSION

J. Pickup, H. Keen, E. Kohner, 1978, The Lancet.

Subcutaneous degradation of insulin

R. W. Stevenson, 1982, Diabetologia.

Comparison of the glucose dependency of glucagon-like peptide-1 (7-37) and glyburide in vitro and in vivo.

D. Hargrove, N. A. Nardone, R. W. Stevenson, 1996, Metabolism: clinical and experimental.

Importance of the route of intravenous glucose delivery to hepatic glucose balance in the conscious dog.

A. Cherrington, G. Hendrick, P. Williams, 1987, The Journal of clinical investigation.

EVIDENCE THAT PROTEASE INHIBITORS REDUCE THE DEGRADATION OF PARATHYROID HORMONE AND CALCITONIN INJECTED SUBCUTANEOUSLY

J. Parsons, B. Rafferty, R. W. Stevenson, 1979, British journal of pharmacology.

Use of protease inhibitors to protect subcutaneously injected peptide hormones against local degradation [proceedings].

J. Parsons, B. Rafferty, R. W. Stevenson, 1977, British journal of pharmacology.

Prolonged Hypoglycemic Effect in Diabetic Dogs Due to Subcutaneous Administration of Insulin in Liposomes

J. Parsons, B. E. Ryman, H. Patel, 1982, Diabetes.

Double isotope estimates of intestinal calcium absorptio in rats: Enhancement by parathyroid hormone and 1,25-dihydroxycholecalciferol

J. Parsons, B. Rafferty, D. Gray, 1976, Calcified Tissue Research.

Use of liposomes to aid intestinal absorption of entrapped insulin in normal and diabetic dogs.

J. Parsons, B. E. Ryman, H. Patel, 1982, Biochimica et biophysica acta.

Changes in plasma calcium and in radiocalcium kinetics after termination of 5-week infusions of synthetic parathyroid peptide in dogs.

J. Parsons, J. Reeve, R. W. Stevenson, 1983, Acta endocrinologica.

Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo.

D. Danley, R. McPherson, J. Treadway, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Possibility of Distinct Insulin-Signaling Pathways Beyond Phosphatidylinositol 3-Kinase–Mediating Glucose Transport and Lipogenesis

E. M. Gibbs, R. W. Stevenson, D. Kreutter, 1998, Diabetes.

Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4).

J. Pessin, J. Stock, J. Mcneish, 1995, The Journal of clinical investigation.

Glucagon-like peptide-1 and analogs: A structure/function analysis

J. Withka, D. Singleton, W. Massefski, 2002 .

Insulin, glucagon, and glucose as regulators of hepatic glucose uptake and production in vivo.

N. Abumrad, A. Cherrington, P. Williams, 1987, Diabetes/metabolism reviews.

Structure-activity relationships in a series of NPY Y5 antagonists: 3-amido-9-ethylcarbazoles, core-modified analogues and amide isosteres.

C. Mack, Robert M. Oliver, R. Hank, 2003, Bioorganic & medicinal chemistry letters.

Pathological and therapeutic implications of the cellular and humoral responses to parathyrin.

J. Parsons, P. Meunier, J. Reeve, 1981, Biochemical Society Transactions.

Glucagon as a regulator of hepatic glucose production in vivo.

A. Cherrington, R. W. Stevenson, K. Steiner, 1987, Biochemical Society Transactions.

Age-related changes in amylin secretion

J. Morley, F. Kaiser, R. W. Stevenson, 1996, Mechanisms of Ageing and Development.

Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide.

M. Carty, W. Soeller, P. Butler, 1998, Diabetes.

Regulation of cell surface GLUT4 in skeletal muscle of transgenic mice.

C. Wilson, T. Reynolds, S. Cushman, 1997, The Biochemical journal.

Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agents.

R. Volkmann, E. M. Gibbs, J. Eggler, 1991, Journal of medicinal chemistry.

Substituted Dihydrobenzopyran and Dihydrobenzofuran Thiazolidine-2,4- diones as Hypoglycemic Agents.

R. Volkmann, E. M. Gibbs, J. Eggler, 1991 .

The synthetic 32-46 fragment of human growth hormone increases insulin and glucagon levels in the conscious dog.

A. Cherrington, P. Williams, N. Stebbing, 1987, Metabolism: clinical and experimental.

Structure-function analysis of a series of glucagon-like peptide-1 analogs.

D. Singleton, W. Massefski, R. W. Stevenson, 2009, The journal of peptide research : official journal of the American Peptide Society.

Further Evidence for Non-Pancreatic Insulin Immunoreactivity in Guinea Pig Brain

R. W. Stevenson, 1983, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Benzyloxazolidine-2,4-diones as potent hypoglycemic agents.

T. T. Chou, R. L. Dow, R. W. Stevenson, 1991, Journal of medicinal chemistry.

Prolonged Hypoglycemic Effect in Diabetic Dogs Due to Subcutaneous Administration of Insulin in Liposomes

J. Parsons, B. E. Ryman, H. Patel, 1982, Diabetes.

In vivo STUDIES ON AN ANTAGONIST OF PARATHYROID HORMONE [Nle‐8, Nle‐18, Tyr‐34]bPTH‐(3–34)AMIDE

J. Potts, J. Parsons, D. Gray, 1982, British journal of pharmacology.